PREVECEUTICAL INITIATES PREPARATION OF PROOF-OF-CONCEPT PRECLINICAL STUDY FOR ITS DIABETES & OBESITY DUAL GENE THERAPY PROGRAM
VANCOUVER, BC, Dec. 4, 2023 /PRNewswire/ - PreveCeutical Medical Inc. , is pleased to announce that it has started preparations to accelerate completion of its preclinical dual gene therapy...